We’re hiring a Senior Medical Manager (SMM) to lead medical strategy and scientific engagement across our cardiovascular (CV) portfolio. In this senior role, you will translate evidence into impactful medical education, shape scientific exchange with external experts, and partner cross‑functionally to advance patient outcomes and brand objectives. Reporting to the Senior Director, Medical Affairs you will: Lead and execute the medical strategy for one or more CV products/portfolios, aligned to country and regional objectives. Build trusted relationships with external experts; coordinate advisory boards, medical education initiatives, and scientific communications. Develop and refine the scientific narrative for the therapy area; capture actionable insights to identify knowledge gaps and inform evidence generation (including real‑world data). Collaborate with Brand, Regulatory, Health Economics and cross‑functional teams to ensure integrated, medically led plans. Review promotional materials for Code compliance and act as second signatory where required. Champion process improvements and lead cross‑functional projects that elevate Medical Affairs delivery. Your skills: Degree in nursing, pharmacy, or a related scientific discipline; advanced degree (PhD, PharmD) preferred. 7 years’ pharmaceutical/biopharma experience; laboratory or clinical research exposure advantageous. Knowledge of the CV therapy area highly advantageous Proven experience in external engagement, scientific communication, and compliant review processes. Influential collaborator with excellent leadership, planning, communication, and stakeholder management skills. Apply now to shape medical strategy, elevate scientific engagement, and make a meaningful impact for patients. Applications Close on March 11th, 2026 About CSL Seqirus CSL Seqirus is part of CSL. As one of the largest influenza vaccine providers in the world, CSL Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. With state-of-the-art production facilities in the U.S., the U.K. and Australia, CSL Seqirus utilizes egg, cell and adjuvant technologies to offer a broad portfolio of differentiated influenza vaccines in more than 20 countries around the world. To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/ . Our Benefits For more information on CSL benefits visit How CSL Supports Your Well-being | CSL . You Belong at CSL At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future. To learn more about inclusion and belonging visit https://www.csl.com/careers/inclusion-and-belonging Equal Opportunity Employer CSL is an Equal Opportunity Employer. If you are an individual with a disability and need a reasonable accommodation for any part of the application process, please visit https://www.csl.com/accessibility-statement . Watch our ‘On the Front Line’ video to learn more about CSL Seqirus
